Twelve scientific teams in more than a dozen states will receive National Institutes of Health (NIH) grants to study effective ways to prevent and treat HIV/AIDS among people in the criminal justice system. The grants, announced ...
Sep 23, 2010
not rated yet
0
(PhysOrg.com) -- HIV-1 protease inhibitors were added as a component of highly active antiretroviral therapy (HAART) in the mid-1990s, and have played a key role in that treatment regimen ever since. However, ...
Sep 17, 2010
not rated yet
0
The BC Centre of Excellence in HIV/AIDS (BC-CfE) published an important study today in the globally respected Lancet medical journal. The study strongly reinforces the view that the benefits of highly active antiretroviral ...
Jul 19, 2010
4 / 5 (1)
0
A Canadian study being presented at the forthcoming International AIDS Society (IAS) conference shows that the annual number of new HIV diagnoses has more than halved since the introduction of highly active antiretroviral ...
Jul 18, 2010
not rated yet
0
In a policy report published in Science, an internationally recognized peer-reviewed journal, leading experts in HIV/AIDS research have warned that failure to meet a pledge for universal access to HIV therapy and funding cuts t ...
Jul 08, 2010
not rated yet
0
Increasing highly active antiretroviral therapy (HAART) treatment for people with HIV/AIDS will provide significant cost savings over a relatively short period of time, according to a formal economic analysis led by researchers ...
Jul 07, 2010
not rated yet
0
(PhysOrg.com) -- The Human Immunodeficiency Virus (HIV) is widely treated using highly active antiretroviral therapy (HAART), which patients must continue throughout their lives. Now a new study suggests the patients’ own ...
Jun 18, 2010
5 / 5 (2)
0
|
Researchers from the BC Centre for Excellence in HIV/AIDS (BC-CfE) and the University of British Columbia today released a comprehensive study revealing that the 2008 IAS-USA therapy guidelines for commencing HIV treatment ...
Jun 07, 2010
not rated yet
0
Research from the University of Leeds has identified how the virus which causes Kaposi's Sarcoma replicates and spreads - opening a door to a possible new treatment for the disease.
May 06, 2010
5 / 5 (1)
0
Johns Hopkins scientists have found that a safe and inexpensive antibiotic in use since the 1970s for treating acne effectively targets infected immune cells in which HIV, the virus that causes AIDS, lies ...
Mar 19, 2010
4.8 / 5 (21)
1
|
A comprehensive population-based study, conducted by the BC Centre for Excellence in HIV/AIDS (BC-CfE) and presented at the 17th Conference on Retroviruses and Opportunistic Infections in San Francisco, shows that expanded ...
Feb 18, 2010
not rated yet
0
Highly active antiretroviral therapy has increased the longevity and quality of life for people living with human immunodeficiency virus. But it requires strict adherence in taking the medicine, something that is extremely ...
Oct 22, 2009
not rated yet
0
Mothers receiving highly active antiretroviral therapy (HAART) to treat HIV-1 infection are less likely than untreated mothers to transmit the virus to their newborns through breastfeeding, according to a new study. The findings, ...
Oct 16, 2009
5 / 5 (1)
0
An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped. Their finding was published ...
Oct 15, 2009
5 / 5 (1)
0
More than half of clinic patients infected with the human immunodeficiency virus (HIV) report they also drink heavily. While highly active antiretroviral therapy has helped to reduce HIV-related cognitive and motor deficits, ...
Jul 23, 2009
not rated yet
0
